IL6 and COVID-19: The authors of the study concluded that homogenous hyperinflammatory innate immune responses (higher plasma concentrations of TNF-α and IL-6) in COVID-19 patients are combined with defective adaptive immune responses due to profound lymphopenia, exhausted T cells and decreased functionality.